Truist Financial
CKPT

Truist Financial’s Checkpoint Therapeutics CKPT Stock Holding History

Truist Financial’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,396
Closed -$15K – 2583
2022
Q3 		$15K Hold
1,396
– – ﹤0.01% 2492
2022
Q2 		$14K Hold
1,396
– – ﹤0.01% 2611
2022
Q1 		$25K Hold
1,396
– – ﹤0.01% 2650
2021
Q4 		$43K Sell
1,396
-21
-1% -$695 ﹤0.01% 2708
2021
Q3 		$47K Buy
1,417
+321
+29% +$9.49K ﹤0.01% 2668
2021
Q2 		$32K Hold
1,096
– – ﹤0.01% 2685
2021
Q1 		$34K Buy
1,096
+17
+2% +$570 ﹤0.01% 2599
2020
Q4 		$29K Buy
1,079
+79
+8% +$2K ﹤0.01% 2515
2020
Q3 		$27K Hold
1,000
– – ﹤0.01% 2410
2020
Q2 		$20K Hold
1,000
– – ﹤0.01% 2363
2020
Q1 		$15K Hold
1,000
– – ﹤0.01% 2342
2019
Q4 		$17K Buy
+1,000
New +$16.7K ﹤0.01% 2468

Other funds holding CKPT

TC
TwinBeech Capital Purchase, New York $965M AUM 0.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Truist Financial's CKPT Position: Q4 2022 in Review

Truist Financial sold out of Checkpoint Therapeutics (CKPT) in Q4 2022, closing a stake of 1,396 shares — an estimated $15K sold.

Truist Financial first reported a position in CKPT in Q4 2019 and held it in 12 quarters. The position peaked at $47K in Q3 2021. 40 funds tracked by Wall St. Rank hold CKPT as of Q4 2022.

  • Truist Financial reported no remaining Checkpoint Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Truist Financial sold 1,396 Checkpoint Therapeutics shares in Q4 2022, an estimated $15K.
  • Truist Financial first reported a position in Checkpoint Therapeutics in Q4 2019 and held it in 12 quarters.
  • Truist Financial's Checkpoint Therapeutics position peaked at $47K in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q4 2022.

Based on Truist Financial's 13F filing for Q4 2022, filed 17 Feb 2023.